Greenwich LifeSciences, Inc.
GLSI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4,092 | $6,989 | $13,468 | $27,204 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $4,092 | $6,989 | $13,468 | $27,204 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $2 | $5 | $9 | $13 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $5 | $9 | $13 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4,094 | $6,995 | $13,477 | $27,217 |
| Liabilities | – | – | – | – |
| Payables | $1,178 | $35 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $382 | $259 | $263 | $385 |
| Total Curr. Liab. | $1,560 | $294 | $263 | $385 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,560 | $294 | $263 | $385 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $13 | $13 | $13 | $13 |
| Retained Earnings | -$66,153 | -$50,365 | -$41,473 | -$33,648 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $68,674 | $57,052 | $54,674 | $60,466 |
| Total Equity | $2,534 | $6,700 | $13,214 | $26,832 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4,094 | $6,995 | $13,477 | $27,217 |
| Net Debt | -$4,092 | -$6,989 | -$13,468 | -$27,204 |